Drugs / MTX at a dose ranging from 10 mg/week at baseline to 20 mg/week at week 8
MTX at a dose ranging from 10 mg/week at baseline to 20 mg/week at week 8
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01245452 Comparator | May 2010 → Jun 2013 | rheumatoid arthritis | Patrick Durez | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MTX at a dose ranging from 10 mg/week at baseline to 20 mg/week at week 8 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01245452 ↗ |